Bedrosian Camille L
- SEC CIK
- 0001326969
In the past year, 4 open-market sale filings worth $689.0K and no purchases.
Current role at each company
- AMLX Amylyx Pharmaceuticals, Inc.Chief Medical Officeras of Sep 14, 2026
- CRNX Crinetics Pharmaceuticals, Inc.Directoras of Sep 1, 2026
- RYTM Rhythm Pharmaceuticals, Inc.Directoras of Jun 26, 2025
- RARE Ultragenyx Pharmaceutical Inc.EVP and Chief Medical Officeras of Mar 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $689.0K
- 4 filings
- Net
- −$689.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Bedrosian Camille L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AMLX Amylyx Pharmaceuticals, Inc.
Chief Medical Officer7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 (view filing)4:00 PM ET | Sep 10 | 4 days | Bedrosian Camille LChief Medical Officer | SSale | −10.0K | $32.40 | −$324.9K | −3.5%278.1K after | 2 lots |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Bedrosian Camille LChief Medical Officer | SSale | −6.46K | $14.58 | −$94.2K | −3.7%169.3K after | |
| Dec 3, 2025 (view filing) | Dec 1 | 2 days | Bedrosian Camille LChief Medical Officer | SSale | −6.58K | $14.35 | −$94.4K | −3.6%175.8K after | |
| Oct 2, 2025 (view filing) | Sep 30 | 2 days | Bedrosian Camille LChief Medical Officer | SSale | −12.0K | $14.58 | −$175.5K | −6.2%182.3K after | |
| Apr 2, 2025 (view filing) | Mar 31 | 2 days | Bedrosian Camille LChief Medical Officer | SSale | −12.4K | $3.47 | −$43.1K | −6.0%194.4K after | |
| Dec 3, 2024 (view filing) | Dec 2 | 1 day | Bedrosian Camille LChief Medical Officer | SSale | −5.42K | $5.54 | −$30.0K | −3.8%138.4K after | |
| Oct 2, 2024 (view filing) | Sep 30 | 2 days | Bedrosian Camille LChief Medical Officer | SSale | −11.4K | $3.20 | −$36.6K | −7.4%143.8K after |
RARE Ultragenyx Pharmaceutical Inc.
EVP and Chief Medical Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Bedrosian Camille LEVP and Chief Medical Officer | SSale | −3.88K | $45.25 | −$175.6K | −7.7%46.7K after | |
| Mar 3, 2022 (view filing) | Mar 1 | 2 days | Bedrosian Camille LEVP and Chief Medical Officer | SSale | −2.82K | $66.62 | −$187.9K | −7.7%33.9K after | |
| Feb 1, 2022 (view filing) | Jan 30 | 2 days | Bedrosian Camille LEVP and Chief Medical Officer | SSale | −1.66K | $66.30 | −$109.9K | −4.3%36.8K after | |
| Oct 18, 2021 (view filing) | Oct 14 | 4 days | Bedrosian Camille LEVP and Chief Medical Officer | SSale | −359 | $81.14 | −$29.1K | −0.9%38.4K after | |
| Sep 2, 2021 (view filing) | Sep 1-2 | 1 day | Bedrosian Camille LEVP and Chief Medical Officer | SSale | −5.00K | $100.11 | −$500.5K | −11.4%38.8K after | 2 lots |